Chi3l1 serum levels are significantly correlated with the 28-joint disease activity score (DAS 28), body surface area (BSA), and psoriasis area and severity index (PASI), thereby contributing to diagnosing and monitoring the severity of joint involvement in patients with psoriatic arthritis [257]. The gene discussed is CHI3L1; the disease is psoriasis.